Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Voi offers people in Bristol e-scooter safety lessons

A Voi scooter in Bristol. Credit: Voi Bristol 23 May 2023: Shared e-scooter company Voi has unveiled dates for safety events aimed at further helping riders in Bristol to ride e-scooters safely. The company has arranged a number of online safety webinars and an in-person event from 27 May onwards. The in-person e-scooter safety event is free of charge and will take place on Saturday 27 May from 8am until 3.40pm at Park 21, University of the West of England, Frenchay Campus. People taking part in the in-person session can learn more about Voi e-scooters, ask questions

Interim report Q1 2023 CGit Holding AB (publ)

Mölndal                                                                                      2023-05-23 Group financial overview Group financial First First Full year 2022 Full year 2021overview quarter quarter 2023 2022Net sales 22 246 27 841 156 113 135 569EBITDA 394 2 629 5 760 4 924Earnings (EBIT) -550 1 721 1 972 1 537Earnings after -637 1 296 1 281 1 000taxEarnings per -0,40 0,82

Brain+ showcased at Danish Dementia Days and at Altenpflege in Germany, Europe’s largest elderly care conference

Copenhagen, Denmark, May 23, 2023 – Brain+ A/S (Nasdaq First North: BRAINP) · Brain+ was featured at The Dementia Days in Copenhagen, the most important annual dementia event in Denmark with over 1,000 municipal dementia coordinators present · Brain+ was selected as one of the most promising new elderly care technology start-ups at the annual German elderly care conference, Altenpflege   · Conference showcasing is essential to build product awareness and relationships with target customers – and has confirmed growing interest in the Brain+ dementia productsFollowing the market

Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day

Herantis Pharma Plc, Press Release, 23 May 2023 at 10:00 A.M. EEST Herantis Pharma Plc (“Herantis”), a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease, today announced that Redeye will be hosting events for investors with Herantis Pharma, CEO Antti Vuolanto, and CFO Tone Kvåle. Lunch meeting: Following the recent announcement of the first-in-human clinical study start, Herantis will give a company update, followed by discussion/Q&A. As an introduction, Redeye analyst Fredrik Thor will give a brief case summary and his view of the

Lindex works to break the taboos around menstruation

Ahead of Menstrual Hygiene Day on May 28, Lindex raises the issue of menstruation to break the surrounding taboos. The fashion company has also decided that part of the sales will be used to spread knowledge about menstruation and to offer training in women's hygiene. Lindex has decided that for the rest of 2023, two per cent of the sales of period-proof panties, from the fashion company's femtech brand Female Engineering, will be donated to the organisation WaterAid. This will combat menstrual poverty and promote education around women's hygiene. In total, this is estimated to

KLAR Partners enters the Netherlands market as a growth partner to hallo, with the mission to build Europe’s leading SME-focused IT services provider

Funds advised by KLAR Partners Limited (“KLAR Partners” or “KLAR”) have signed an agreement to invest as a growth partner in hallo,. As a leading Dutch provider of mission-critical IT services for SMEs, the company is well-positioned for accelerated growth and, with support from KLAR, aspires to become the champion in the growing SME market in Europe. KLAR will invest alongside the present owners, Vortex Capital Partners and hallo’s management.hallo,’s automated services platform provides small and medium-sized clients with a one-stop-shop for mission-critical IT services. Services include

Peikko chosen as a supplier for the new Jorvi Hospital extension in Finland

Peikko has been selected as a supplier for Jorvi Hospital's new extension in Espoo, Finland. The order includes 5.4 km of DELTABEAM® Green composite beams and nearly 80 PETRA® Green hollow-core slab hangers. Peikko's deliveries to the site will begin in August 2023 and continue until September 2024. Hospital operations in the new premises are expected to begin in 2026.SRV is the main contractor on the 259 M€ project owned by HUS Helsinki University Hospital. Three architects collaborated on the five-story building: Lukkaroinen Architects Oy, UKI Architects, and Tähti-Set Architects Oy. The

Efficient tires make underground mining safe and smooth – Nokian Tyres Armor Gard 2 Mine, now available in smaller size of 9.00-20

For drill rigs in the harsh mining conditions, Nokian Tyres Armor Gard 2 Mine offers excellent cut resistance, great handling and a long service-life. The tire has only been available in size 10.00-20. Now the new size, 9.00-20, makes its qualities available for even more vehicles.Kimmo Kekki, a Global Product Manager at Nokian Heavy Tyres, is happy to announce the new member of the tire family:  “Nokian Tyres Armor Gard 2 Mine has already proven its value among its customers,” Kekki says. “And we are excited to introduce this new size, as now more and more mining workers get to feel

UPM Biochemicals and URSA develop new sustainable insulation to achieve step change in the environmental performance of the construction materials industry

Image_URSA_glass wool [UPM Biochemicals und URSA entwickeln neue nachhaltige Dämmstoffe für die Baustoffindustrie] UPM Biochemicals und URSA entwickeln neue nachhaltige Dämmstoffe für die Baustoffindustrie (UPM, Helsinki, 23.05.2023 at 10:00 EEST) – UPM Biochemicals  and URSA , one of the leading producers of glass wool and mineral wool in Europe, today announced the development of more environmentally friendly building insulation that will help to reduce energy consumption and lower CO\2\ emissions. URSA will produce

Interim results from study of AccYouRate and Siena Hospital on wearable solutions for children with Rett syndrome

Earlier AccYouRate released the interim results of its latest study focusing on pediatric disability. The study, which was coordinated by the University Hospital of Siena Hospital, and led by Dr. Claudio De Felice, explored the use of AccYouRate's wearable devices and Red Cross Italia caring services for the monitoring of children with Rett syndrome.    The results demonstrated that wearables technology can provide reliable and easily interpretable data to help determine the effects of therapies and care at home, which can then provide information for appropriate remedies. Monitoring

Katalysen Ventures publishes report for the First Quarter 2023

Katalysen Ventures AB (publ) hereby publishes the report for the first quarter of 2023. The full report is available immediately as an attached document, and on the company's website. Below is a summary of the report. In short, the portfolio showed resilience during turbulent market conditions. The aggregated portfolio value decreased by 4.5 percent following downward adjustments in the valuations of five individual ventures. Continued adjustments in one venture contributed the majority of the change. Cost optimization and a reorganized team has resulted in reduced operational expenditure.

BioStock: Dicot heading towards summer with strengthened team and finances

In August, Dicot is expected to take its biggest step as a development company with the planned initiation of a phase I clinical trial for the drug candidate LIB-01. Over the past quarter, the company has worked hard to strengthen both its team and finances in preparation for the study start. BioStock reached out to CEO Elin Trampe for her thoughts on the past quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/dicot-heading-towards-summer-with-strengthened-team-and-finances/ This is a press release from BioStock - Connecting

Internet Vikings to Strengthen U.S. Presence with Maine and Wyoming Expansion

Internet Vikings is leveraging its partnership with a leading North American B2B technology provider to expand its presence in the U.S. iGaming and online sports betting markets, with anticipated launches in Maine and Wyoming later this year. This move marks the latest step in a collaboration that began in April 2022 and has already seen the companies team up in other U.S. states. Rickard Vikström, Founder and CEO of Internet Vikings expressed his contentment by stating that their continued work with a leading North American technology provider as it expands its presence in the US

Rejlers expands cooperation with LKAB

Rejlers has been commissioned to develop the logistics system for the new and deeper main level planned at LKAB’s Malmberget mine. The goal is to create new technical solutions that will set a new world standard for sustainable mining at great depths.One of the world’s largest underground mines is located in Malmberget in Gällivare Municipality. The current mining operations are conducted 1250 m below ground. Planning is underway for mining operations beyond year 2060 with major investments in infrastructure, innovative mining methods and new ways of working. Rejlers has been given a

Immunovia Publishes Interim Report for January-March 2023

January-March 2023 · Net sales amounted to kSEK 520 (182) divided by sales of tests kSEK 379 (122) and royalties kSEK 141(60). · Net earnings were MSEK -51.7 (-44.1) and earnings per share before and after dilution were SEK -2.28 (-1.95). · Cash Flow from operating activities were MSEK -39.7 (-46.1). · Cash and equivalents at the end of the period amounted to MSEK 68.2 (239.8). · On January 17, the Company appointed Lara E. Sucheston-Campbell as Head of Clinical and Medical Affairs · On January 19, the Company announced that a process to re-align the Swedish operations

Starbreeze announces terms for its rights issue of approximately SEK 450 million

On April 28, 2023, Starbreeze AB (publ) (“Starbreeze” or the “Company”) announced that the Board of Directors had resolved on a rights issue of class A and class B shares of approximately SEK 450 million before transaction costs (the “Rights Issue”), subject to approval by an extraordinary general meeting to be held on May 24, 2023 (the "EGM"). The net proceeds from the Rights Issue are intended be used to accelerate investments in game development and third-party publishing to achieve further growth and a diversified games portfolio as well as to strengthen the Company's balance sheet

BioStock: Flerie Invest’s Carl-Johan Spak elected to Lipum’s Board

At Lipum’s Annual General Meeting on May 10, Carl-Johan Spak was elected as a new board member of Lipum. Carl-Johan is a senior advisor at Flerie Invest and will contribute with useful knowledge, his experience from the pharmaceutical industry and previous board assignments. BioStock talked to Carl-Johan Spak about his professional background and his expectations for the role in Lipum.Read the full article at biostock.se: https://www.biostock.se/en/2023/05/flerie-invests-carl-johan-spak-elected-to-lipums-board/ This is a press release from BioStock - Connecting Innovation & Capital.

Interim report January – March 2023

First quarter in brief  · Net sales amounted to 16,1 million SEK (9,9), which means a sales growth of 63 percent. ·Operating profit amounted to -2 million SEK (-3,6), corresponding to an operating margin of -13 percent (-37). ·Net profit for the period amounted to -2,2 million SEK (-3,5). ·Earnings per share amounted to -0.05 SEK (-0.08). Significant events during the first quarter During the first quarter SyMRI received regulatory approval in Singapore, UK and Canada. Significant events after the first quarter Nothing to report.CEO comments

There are no items matching the current filter
There are no more items matching the current filter
Back to top